A menthol-based solid dispersion technique for enhanced solubility and dissolution of sulfamethoxazole from an oral

Bibi F Choonara1, Yahya E Choonara, Pradeep Kumar

  • 1Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa.

AAPS Pharmscitech
|January 1, 2015
PubMed

Insights

Menthol solid dispersions significantly enhanced the solubility and dissolution of sulfamethoxazole, a poorly soluble antibiotic. This formulation approach improved oral drug delivery by controlling drug release rates.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems
  • Materials Science

Background:

  • Sulfamethoxazole, a BCS Class II drug, exhibits poor intrinsic solubility, limiting its oral bioavailability.
  • Developing effective drug delivery systems is crucial for enhancing the therapeutic efficacy of poorly soluble drugs like sulfamethoxazole.

Purpose of the Study:

  • To formulate and characterize menthol-based solid dispersions of sulfamethoxazole to improve its solubility and dissolution.
  • To evaluate the physicochemical properties and in vitro drug release of sulfamethoxazole-loaded matrix tablets.

Main Methods:

  • Preparation of sulfamethoxazole-menthol solid dispersions and hydroxypropyl methylcellulose (HPMC) matrix tablets.
  • Characterization using techniques such as crystallinity, melting point, molecular transitions, and textural analysis.
  • In vitro evaluation of swelling, degradation, solubility, and drug release profiles.

Main Results:

  • Menthol-based solid dispersions significantly improved sulfamethoxazole solubility and dissolution.
  • Matrix tablets demonstrated controlled in vitro drug release, with fractional releases ranging from 0.714 to 0.970.
  • Varying menthol concentrations influenced drug release rates over extended periods (12-56 hours).

Conclusions:

  • Menthol serves as an effective hydrophilic carrier for sulfamethoxazole, acting as a solubilizing and release-retarding agent.
  • Menthol-based solid dispersions offer a promising strategy for enhancing the oral delivery of poorly soluble drugs.
  • The developed matrix tablets show potential for controlled release of sulfamethoxazole, improving its therapeutic profile.

Related Concept Videos

Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
462
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
2.1K
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
318
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
793
Factors Influencing Drug Absorption: Drug Dissolution01:27

Factors Influencing Drug Absorption: Drug Dissolution

The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.9K
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
250